tykhr
sign in
free sign up
Alkermes Plc
Drug Manufacturers - Specialty & Generic
Healthcare
ALKS
168 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
27.49
52 week high
36.00
high
28.03
52 week low
0.00
low
27.47
growth
-2.80 %
previous Close
27.63
P/E ratio
market cap
4.45 B
div yield
0
usd
Jun 2025
qoq
revenue
391 M
27.45 %
net incoming
87.10 M
287.72 %
eps
0.00 %
78.69 %
eps surprise
36.16 %
net profit margin
22.30 %
14.00 %
operating incoming
92.98 M
574.14 %
net change in cash
121 M
11.72 %
cash on hand
521 M
30.36 %
cost of revenue
0.00 %
top